Medline Inc. (MDLN) stock
MDLNNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 4, 2026Score 2/3068% above fair value
$39.16+1.48 (+3.93%)
Close on Nov 18, 2026Market cap $51.48BP/E –Yield –
Medline free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Medline's free cash flow for the twelve months ending Sep 26, 2026 was $1.90B. For fiscal 2025 it was $1.30B, down 8.3% from the year before.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.30B | -8.3% |
| FY2024 | Dec 31, 2024 | $1.42B | +0.4% |
| FY2023 | Dec 31, 2023 | $1.41B | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $884.00M | +65.2% |
| Q2 FY2026 | Jun 27, 2026 | $604.00M | +594.3% |
| Q1 FY2026 | Mar 28, 2026 | $316.00M | -45.9% |
| Q4 FY2025 | Dec 31, 2025 | $91.00M | – |
| Q3 FY2025 | Sep 27, 2025 | $535.00M | – |
| Q2 FY2025 | Jun 28, 2025 | $87.00M | – |
| Q1 FY2025 | Mar 29, 2025 | $584.00M | – |
See a number that looks wrong?